Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Leap Therapeutics logo — company profile

Leap Therapeutics

Founded 2011 United States Cambridge, United States 51 employees Post Ipo Equity Total: $266.50M Biotechnology, Life Sciences

General Information

Company Name Leap Therapeutics
Founded Year 2011
Location United States Cambridge, United States +1
Founders / Decision Makers
Team member
Employees 51
Industries Biotechnology, Life Sciences
Funding Stage Post Ipo Equity
Social

Get notified when Leap Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Leap Therapeutics

### Leap Therapeutics: Acquiring Novel Therapeutics at the Leading Edge of Cancer Research

Leap Therapeutics is a clinical-stage biopharmaceutical company that focuses on acquiring and developing novel therapeutics at the forefront of cancer research. Founded in 2011 and headquartered in the United States, the company has attracted significant attention from notable investors.

Notably, Gilead Sciences, Laurion Capital, Rock Springs Capital, Samsara BioCapital, and 683 CAPITAL have participated in its latest $40.00M Post-IPO Equity investment on 10 April 2024.

With a clear focus on the biotechnology industry, Leap Therapeutics has positioned itself as an intriguing investment opportunity in the oncology therapeutics space. For more information, interested parties can visit the company's website at www.leaptx.com or access public filings with the SEC via EDGAR or investors.leaptx.com.

Taxonomy: biopharmaceutical, clinical-stage, cancer research, therapeutics, oncology, drug development, clinical trials, cancer therapy, innovation

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 5
Investor Investor Investor Investor Investor
10 Apr 2024
Post-IPO Equity •••••• - 22 Sep 2021
Post-IPO Equity •••••• - 18 Jun 2020
Post-IPO Equity •••••• 1
Investor
03 Jan 2020
Post-IPO Equity •••••• 1
Investor
11 Jul 2019

View All 10 Funding Rounds

Leap Therapeutics Alternatives & Competitors

Leap Therapeutics vs
EMulate Therapeutics, Inc.
EMulate Therapeutics, Inc. United States

A modern approach to the treatment of cancer and other serious diseases.

11 employees
Biotechnology
Compare Leap Therapeutics vs EMulate Therapeutics, Inc.
Leap Therapeutics vs
Galera Therapeutics, Inc.
Galera Therapeutics, Inc. United States

Transforming the science and treatment of cancer

IPO
11 employees
Biotechnology, Health and Wellness
Compare Leap Therapeutics vs Galera Therapeutics, Inc.
Leap Therapeutics vs
Abalos Therapeutics GmbH
Abalos Therapeutics GmbH Germany

Abalos is harnessing the power of arenaviruses in a differentiated immuno-virotherapy approach to fi...

Unknown
22 employees
Biotechnology
Compare Leap Therapeutics vs Abalos Therapeutics GmbH

FAQ About Leap Therapeutics

Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research. For more information about Leap Therapeutics, visit http://www.leaptx.com or our public filings with the SEC that are available via ED...
Leap Therapeutics was founded in 2011.
Leap Therapeutics is headquartered in Cambridge, United States.
Leap Therapeutics operates in the following industries: Biotechnology, Life Sciences.
Leap Therapeutics has approximately 51 employees.
Leap Therapeutics has completed 10 funding rounds, raising a total of $266.50M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Leap Therapeutics include EMulate Therapeutics, Inc., Galera Therapeutics, Inc., Abalos Therapeutics GmbH, PRUNUS Therapeutics, Gladius Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Leap Therapeutics and EMulate Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Leap Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy